MX2014006255A - Tratamientos neurologiocos con metaloporfirina. - Google Patents

Tratamientos neurologiocos con metaloporfirina.

Info

Publication number
MX2014006255A
MX2014006255A MX2014006255A MX2014006255A MX2014006255A MX 2014006255 A MX2014006255 A MX 2014006255A MX 2014006255 A MX2014006255 A MX 2014006255A MX 2014006255 A MX2014006255 A MX 2014006255A MX 2014006255 A MX2014006255 A MX 2014006255A
Authority
MX
Mexico
Prior art keywords
metalloporphyrin
neurological treatments
neurological
treatments
exposure
Prior art date
Application number
MX2014006255A
Other languages
English (en)
Inventor
Manisha Patel
Original Assignee
Univ Colorado Regents
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Colorado Regents filed Critical Univ Colorado Regents
Publication of MX2014006255A publication Critical patent/MX2014006255A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
    • A61B17/17—Guides or aligning means for drills, mills, pins or wires
    • A61B17/1739—Guides or aligning means for drills, mills, pins or wires specially adapted for particular parts of the body
    • A61B17/1742—Guides or aligning means for drills, mills, pins or wires specially adapted for particular parts of the body for the hip
    • A61B17/1746—Guides or aligning means for drills, mills, pins or wires specially adapted for particular parts of the body for the hip for the acetabulum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/10—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges for stereotaxic surgery, e.g. frame-based stereotaxis
    • A61B90/11—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges for stereotaxic surgery, e.g. frame-based stereotaxis with guides for needles or instruments, e.g. arcuate slides or ball joints
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/10—Arrangements for locking
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T403/00—Joints and connections
    • Y10T403/32—Articulated members
    • Y10T403/32254—Lockable at fixed position
    • Y10T403/32426—Plural distinct positions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dentistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Mechanical Engineering (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe métodos y composiciones para el tratamiento de un sujeto que sufre de exposición a un agente de amenaza química.
MX2014006255A 2011-12-02 2012-12-03 Tratamientos neurologiocos con metaloporfirina. MX2014006255A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161566530P 2011-12-02 2011-12-02
PCT/US2012/067633 WO2013130150A2 (en) 2011-12-02 2012-12-03 Metalloporphyrin neurological treatments

Publications (1)

Publication Number Publication Date
MX2014006255A true MX2014006255A (es) 2015-04-10

Family

ID=48654725

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014006255A MX2014006255A (es) 2011-12-02 2012-12-03 Tratamientos neurologiocos con metaloporfirina.

Country Status (12)

Country Link
US (1) US9295674B2 (es)
EP (1) EP2785339A4 (es)
JP (2) JP2015500244A (es)
KR (1) KR20140109386A (es)
CN (1) CN104080453A (es)
AU (1) AU2012371568B2 (es)
CA (1) CA2856552A1 (es)
HK (1) HK1200728A1 (es)
IL (1) IL232673A0 (es)
MX (1) MX2014006255A (es)
RU (1) RU2623207C2 (es)
WO (1) WO2013130150A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104080453A (zh) 2011-12-02 2014-10-01 科罗拉多大学董事会,法人团体 金属卟啉神经治疗
EP3071574A4 (en) * 2013-11-22 2017-05-10 Aeolus Sciences, Inc. Synthesis and formulations of porphyrin compounds
US20220387416A1 (en) * 2019-10-25 2022-12-08 Cmc Pharmaceuticals, Inc. Atropine-scopolamine with enhanced stability

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800188A (en) * 1987-03-20 1989-01-24 Hoechst Celanese Corp. Method for supporting metalloporphyrins on polybenzimidazole porous articles
US5081115A (en) * 1987-10-15 1992-01-14 The Board Of Trustees Of The Leland Stanford Junior University Method to prevent neonatal jaundice with metalloporphyrin compositions
US5994339A (en) 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
WO1996009053A1 (en) 1994-09-20 1996-03-28 Duke University Oxidoreductase activity of manganic porphyrins
WO1998030102A1 (en) * 1997-01-09 1998-07-16 Emory University Non-iron metalloporphyrins and methods of use
ES2198767T3 (es) 1997-11-03 2004-02-01 Duke University Porfirinas sustituidas.
US6479477B1 (en) 1998-04-24 2002-11-12 Duke University Substituted porphyrins
WO2000043395A1 (en) 1999-01-25 2000-07-27 National Jewish Medical And Research Center Substituted porphyrins
EP1392328B1 (en) 2001-01-19 2009-08-12 National Jewish Medical and Research Center Medicament for protection in radiotherapy
JP2005508864A (ja) 2001-06-01 2005-04-07 ナショナル・ジュウィッシュ・メディカル・アンド・リサーチ・センター 糖尿病の治療、または移植術における使用、または免疫寛容の誘導のためのオキシダントスカベンジャー
PT1404319E (pt) * 2001-06-06 2006-08-31 Brookhaven Science Ass Llc Novas metaloporfirinas e suas utilizacoes como radiossensibilizadores para terapia de radiacao
US7485721B2 (en) 2002-06-07 2009-02-03 Duke University Substituted porphyrins
US7008937B2 (en) * 2003-06-10 2006-03-07 Frontier Scientific, Inc. Porphyrins and metalloporphyrins for inhibiting heme iron uptake
JP5608644B2 (ja) * 2008-05-23 2014-10-15 ナショナル ジューイッシュ ヘルス アルキル化種の被爆に関連する損傷の処置方法
JP2013503895A (ja) * 2009-09-02 2013-02-04 ザ リージェンツ オブ ザ ユニバーシティー オブ コロラド，ア ボディー コーポレート 金属ポルフィリン類を使用するミトコンドリア病の処置法
EP2625180B1 (en) 2010-10-06 2016-03-02 Aeolus Sciences, Inc. Porphyrin treatment of neurodegenerative diseases
CN104080453A (zh) 2011-12-02 2014-10-01 科罗拉多大学董事会,法人团体 金属卟啉神经治疗

Also Published As

Publication number Publication date
AU2012371568B2 (en) 2017-06-08
CN104080453A (zh) 2014-10-01
JP2015500244A (ja) 2015-01-05
EP2785339A2 (en) 2014-10-08
IL232673A0 (en) 2014-07-31
EP2785339A4 (en) 2015-11-25
WO2013130150A9 (en) 2013-10-24
RU2014126866A (ru) 2016-01-27
KR20140109386A (ko) 2014-09-15
WO2013130150A2 (en) 2013-09-06
HK1200728A1 (en) 2015-08-14
RU2623207C2 (ru) 2017-06-22
US20150246057A1 (en) 2015-09-03
AU2012371568A1 (en) 2014-06-05
US9295674B2 (en) 2016-03-29
JP2018172419A (ja) 2018-11-08
NZ625066A (en) 2016-05-27
CA2856552A1 (en) 2013-09-06

Similar Documents

Publication Publication Date Title
IL227429A0 (en) The components and methods of cancer treatment
EP2755482A4 (en) COMPOSITIONS AND METHODS OF TREATING CANCER
EP2714081A4 (en) METHODS, COMPOSITIONS AND KIT FOR CREAM TREATMENT
HK1201475A1 (en) Methods and compositions for treating pain
WO2013056148A3 (en) Scd1 antagonists for treating cancer
MX2019011905A (es) Nuevas composiciones para el tratamiento de la esclerosis lateral amiotrofica.
EP2734207A4 (en) NEW COMPOSITIONS AND METHOD FOR THE TREATMENT OF PROSTATE CANCER
IL232530B (en) A combination of factors for cancer treatment
JO3131B1 (ar) مركبات كيميائية
EP2760452A4 (en) METHODS OF TREATING CANCER
GB201103062D0 (en) Method
EP2709612A4 (en) COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CANCER BY TARGETING AND INHIBITING CANCER STEM CELLS
ZA201205004B (en) Methods for treating pancreatic cancer
EP2523944A4 (en) COMPOUNDS AND COMPOSITIONS FOR IMPROVING COGNITION, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT
EP2771341A4 (en) NEW COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
EA201490067A1 (ru) Композиции и способы для лечения рака
EP2635286A4 (en) METHOD FOR THE TREATMENT OF CANCER
PL2589579T3 (pl) Zastosowanie zestawu do obróbki powierzchni zaszpachlowanych gipsem, zatartych gipsem lub otynkowanych gipsem
IL228644A0 (en) Cancer treatment methods
MX343968B (es) Inhibidor de proteasoma delanzomib para uso en el tratamiento de lupus.
EP2920187A4 (en) METHOD FOR THE USE OF BINUCLEAR GOLD (I) COMPOUNDS FOR CANCER TREATMENT
IL229231A0 (en) Preparations and methods for the treatment of cancer
EP2717865A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF BRAIN CANCER
MX2014006255A (es) Tratamientos neurologiocos con metaloporfirina.
HK1188566A1 (zh) 治療癌症的組合物和方法